Amends the Therapeutic Goods Act 1989 to transfer the responsibility for regulatory approval of RU486 from the Minister for Health and Ageing to the Therapeutic Goods Administration.
No documents at present
Circulated by members and senators when they propose to make changes to the bill. For details about the outcome of proposed amendments please refer to either the Votes and Proceedings (House of Representatives) or the Journals (Senate).
Schedules of amendments list amendments agreed to by the second house are communicated to the first house for consideration. Subsequent action by either house may also be included in a schedule.
House of Representatives